Stabilization of membrane bound enzyme profiles by sodium selenite in N-nitrosodiethylamine induced and phenobarbital promoted hepatocarcinogenesis in rats

Biomedicine and Pharmacotherapy

Volumn 57, Issue 3, 2003, Pages 117-123

  Thirunavukkarasu, C ^a,b   Sakthisekaran, D ^a  

^a UNIVERSITY OF MADRAS   (India)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

ATPases; Hepatoma; Selenite

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTINEOPLASTIC AGENT; DIETHYLNITROSAMINE; MEMBRANE ENZYME; PHENOBARBITAL; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME STABILITY; ERYTHROCYTE MEMBRANE; HISTOPATHOLOGY; IN VIVO STUDY; LIVER CARCINOGENESIS; MALE; MEMBRANE STABILIZATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0037705477     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00016-7     Document Type: Article

References (51)

1. Gallegos A., Berggren M., Gasdaska J.R., Powis G. Mechanism of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res. 57:1997;4965-4970.
2. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical roles as component of glutathione peroxidase. Science. 179:1973;588-590.
3. Powis G., Gasdaska J.R., Gasdaska P.Y., Berggren M., Kirkpatrick D.L., Engman L., et al. Selenium and thioredoxin redox system: effects on cell growth and death. Oncol Res. 9:1997;303-312.
4. Shamberger R.J., Tytko S.A., Willis C.E. Antioxidants and cancer. Part VI. Selenium and age-adjusted human cancer mortality. Arch Environ Health. 31:1976;231-235.
5. Schrauzer G.N., White D.A., Schneider C.J. Cancer mortality correlation studies. II. Statistical association with dietary selenium intakes. Bioinorg Chem. 7:1977;35-36.
6. Clark L.C., Cantor K.P., Allaway W.H. Selenium in forage crops and cancer mortality in US countries. Arch Environ Health. 46:1991;37-42.
7. Clark L.C., Combs Jr G.F., Turnbull B.W., Slate E.H., Chalker E.K., Chow J., et al. Effects of selenium. Supplementation for cancer prevention in-patients with carcinoma of the skin: a randomized controlled trial. J Am Med Assoc. 276:1996;1957-1963.
8. Yu S., Zhu Y.J., Li W.G., Huang Q.S., Huang C.Z., Zhang Q.N., et al. A preliminary report on the intervention trials of primary liver cancer in high-risk population with nutritional supplementation in China. Biol Trace Elem Res. 29:1991;289-294.
9. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang H.Q., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J Natl Cancer Inst. 85:1993;1483-1492.
10. Simonetti R.G., Liberati A., Anhiolini C., Pagliaro L. Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol. 8:1997;117-136.
11. Combs Jr G.F., Gray W.P. Chemopreventive agents: selenium. Pharmacol Ther. 79:1998;179-192.
12. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 20:1997;1657-1666.
13. Jiang C., Jiang W., Ip C., Ganther H., Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog. 26:1999;213-225.
14. Kitahara J., Seko Y., Imura N. Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes. Arch Toxicol. 67:1993;497-501.
15. Newborne P.M., Bieri J.G., Briggs G.M., Nesheim M.C. Control of diets in laboratory animal experimentation. Inst Lab Anim. Resour News. 21:1978;A1-12.
16. Yoshiji H., Nakae D., Kinugasa T., Matsuzaki M., Denda A., Suiji T. Inhibitory effect of the iron deficiency on the induction of putative preneoplastic foci rat liver initiated with diethylnitrosoamine and promoted by phenobarbital. Br J Cancer. 64:1991;939-982.
17. Thirunavukkarasu C., Jagadeeswaran R., Babu E., Sakthisekaran D. Inhibitory effect of selenium on N-nitrosodiethylamine-induced and phenobarbital promoted rat liver carcinogenesis. J Clin Biochem Nutr. 28:2000;69-80.
18. Dodge J.T., Mitchell C., Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys. 100:1963;119-130.
19. Quist E.E. Regulation of erythrocyte membrane shape by calcium ion. Biochem Biophys Res Commun. 92:1980;631-637.
20. Bonting S.L. Sodium-potassium activated adenosine triphosphatase and cation transport. Bittar E.E. Membranes and ion transport, vol. 1. 1970;257-363 Wiley-Interscience, London.
21. 2+-ATPase activities in normal, regenerating and malignant cells. Biochim Biophys Acta. 684:1962;67-74.
22. 2+-ATPase from erythrocyte membranes. Biochim Biophys Acta. 728:1983;281-288.
23. Fiske C.H., Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 66:1925;375-400.
24. Mukherjee K.L. Medical laboratory technology. I:1988;320 Tata McGraw-Hill Publishing Company Ltd, New Delhi.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin-phenol reagent. J Biol Chem. 193:1951;265-275.
26. Baggetto L.G. Deviant energetic metabolism of glycolytic cancer cells. Biochemie. 74:1988;959-974.
27. Ebrahim A.S., Babakrishnan K., Sakthisekaran D. Perchloroethylene-induced alterations in glucose metabolism and their prevention by 2-deoxy-D-glucose and vitamin E in mice. J Appl Toxicol. 16:1996;339-348.
28. McKenzie R.C., Rafferty T.S., Beckett G.J. Selenium: an essential element for immune function. Immunol Today. 19:1998;842-845.
29. Combs G.F. Jr. Selenium and cancer. Biochemistry and molecular biology of selenium. 2nd: 1995;Wang, Beijing: Chinese Academy of Science.
30. Combs G.F. Jr. Selenium and cancer. Garewall A.S. Antioxidants and disease prevention. 1997;97-113 NY: CRC Press, New York.
31. Gerbracht U., Eigenbrodt E., Simile M.M., Pascale R.M., Gaspa L., Danio L., et al. Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. Antican Res. 13:1993;1765-1772.
32. Oplatka A., Friedman J.E., Kosenheck K. Galeotti T., Cittadini A., Novi G., Papa S., Smets L.A. Cell membranes and cancer. 1985;117-124 Elsevier Science Publishers, Amsterdam.
33. Stekhoren M.A., Bonting S.L. Transport ATPases: properties and functions. Physiol Rev. 61:1981;1-76.
34. Verna R., Frati L. Galeotti T. Membranes in tumour growth. 1982;515 Elsevier, North Holland.
35. Raikhtin N.T. SSR. Enzymatic hydrolysis of ATP on the surface of neoplastic cells. Vestn Akad Med Nauk. 26:1971;47-50.
36. 2+-ATPases. Biol Res. 26:1993;141-150.
37. Horward A., Barley N.F., Legon S., Walter J.R. Plasma membrane calcium pump isoforms in human and rat liver. Biochem J. 303:1994;275-279.
38. 2+ homeostasis in intact cells. J Cell Biol. 126:1994;1183-1194.
39. Rauchova H., Ledvinkova J., Kalous M., Drahota Z. The effect of lipid peroxidation on the activity of various membrane-bound ATPases in rat kidney. Int J Biochem Cell Biol. 27:1995;251-255.
40. Dawson R.M.C., Hemington N., Lindsay L. The phospholipids of the erythrocyte 'ghosts' of various species. Biochem J. 77:1960;226-230.
41. Thirunavukkarasu C., Sakthisekaran D. Effect of selenium on N-nitrosodiethylamine induced multi-stage hepatocarcinogenesis with reference to lipid peroxidation and enzymic antioxidants. Cell Biochem Funct. 19:2001;27-35.
42. Thirunavukkarasu C., Prince Vijaya Singh J., Thangavel M., Selvendhiran K., Sakthisekaran D. Dietary influence of selenium on the incidence of N-nitrosodiethylamine-induced hepatoma with reference to drug and glutathione metabolizing enzymes. Cell Biochem Funct. 20:2002;347-356.
43. Rajewsky F., Dauber W., Frankenberg H. Liver carcinogenesis by diethylnitrosoamine in the rats. Science. 152:1966;83-85.
44. Bartsch H., Hietanen E., Malavelle C. Carcinogenic nitrosoamines free radical aspects of their action. Free Rad Biol M. 71:1989;637-644.
45. Copeland E.S. A National Institute of Health Workshop Report: free radicals in promotion - a chemical pathology study section workshop. Cancer Res. 43:1983;5631-5634.
46. Fridovich I. Superoxide dismutase. Ann Rev Biochem. 44:1975;147-156.
47. Brawn M., Fridovich I. DNA strand scission by enzymically generated oxygen radicals. Arch Biochem J. 219:1981;1-5.
48. Halliwell B., Gutteridge J.M.C. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J. 219:1984;1-4.
49. Toskulkao C., Glinsukon T. Orn A.S.H., Packer L. Lipid soluble antioxidants biochemistry and clinical application. 1992;567-574 Brikauser Verleg Basel, Switzerland.
50. Liu J., Gilbert K., Parker H.M., Haschek W.M., Milner J.A. Inhibition of 7,12-dimethylbenz (a) anthracene-induced mammary tumors and DNA adducts by dietary selenite. Cancer Res. 51:1991;4613-4615.
51. Thirunavukkarasu C., Sakthisekaran D. Sodium selenite, dietary micronutrient, prevents the lymphocytes DNA damage induced by N -nitrosodiethylamine and phenobarbital promoted experimental hepatocarcinogenesis. J Cell Biochem. 88:2003;578-588.